Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Oct 31, 2024 | (FY)Oct 31, 2023 | (FY)Oct 31, 2022 | (FY)Oct 31, 2021 | (FY)Oct 31, 2020 | (FY)Oct 31, 2019 | (FY)Oct 31, 2018 | (FY)Oct 31, 2017 | (FY)Oct 31, 2016 | (FY)Oct 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -29.09%12.27B | 690.23%17.31B | 15.26%2.19B | -85.19%1.9B | -7.45%12.83B | -21.62%13.86B | -12.55%17.68B | -1.24%20.22B | -25.46%20.47B | 42.81%27.46B |
Net profit before non-cash adjustment | 579.19%5.78B | 78.79%-1.21B | -170.49%-5.69B | 520.87%8.07B | -126.85%-1.92B | -23.67%7.14B | -36.00%9.35B | -14.66%14.62B | -18.38%17.13B | -1.11%20.98B |
Total adjustment of non-cash items | -71.70%3.98B | 15.03%14.06B | 888.28%12.23B | -84.26%1.24B | -1.95%7.86B | 5.35%8.02B | 9.77%7.61B | 24.43%6.93B | 6.24%5.57B | 95.53%5.24B |
-Depreciation and amortization | 5.30%10.46B | 1.20%9.94B | 11.04%9.82B | 6.30%8.84B | 4.00%8.32B | 3.37%8B | 7.22%7.74B | 21.24%7.22B | -8.43%5.95B | 35.36%6.5B |
-Reversal of impairment losses recognized in profit and loss | -57.55%1.95B | 68.64%4.58B | --2.72B | ---- | -60.50%269M | 18.02%681M | 37.38%577M | --420M | ---- | -62.54%109M |
-Share of associates | 81.67%-110M | -1,276.47%-600M | 113.42%51M | -766.67%-380M | 122.27%57M | -34.74%-256M | 25.78%-190M | 1.54%-256M | 22.39%-260M | 21.36%-335M |
-Disposal profit | -726.35%-5.59B | 386.82%892M | 94.28%-311M | -440.66%-5.44B | 24.93%-1.01B | -6.69%-1.34B | -2.95%-1.26B | 14.63%-1.22B | -143.03%-1.43B | 68.34%-588M |
-Net exchange gains and losses | 54.99%-194M | -979.59%-431M | 126.78%49M | 20.43%-183M | -152.39%-230M | 230.08%439M | -49.04%133M | -67.21%261M | 235.14%796M | -60.93%-589M |
-Remuneration paid in stock | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 31.03%38M | 16.00%29M |
-Other non-cash items | -700.32%-2.54B | -220.20%-317M | 93.82%-99M | -454.65%-1.6B | -8.50%452M | -18.75%494M | 18.98%608M | 7.81%511M | 301.69%474M | -44.60%118M |
Changes in working capital | -43.51%2.51B | 202.35%4.45B | 41.27%-4.35B | -207.60%-7.4B | 630.05%6.88B | -280.53%-1.3B | 154.02%719M | 40.10%-1.33B | -280.06%-2.22B | 126.44%1.23B |
-Change in receivables | 278.95%3.83B | 74.36%-2.14B | -268.29%-8.34B | 172.20%4.95B | -42.37%1.82B | 48.40%3.16B | 198.11%2.13B | 41.47%-2.17B | -6,175.41%-3.71B | 116.58%61M |
-Change in inventory | -71.30%769M | 335.00%2.68B | 84.37%-1.14B | -473.15%-7.3B | 438.82%1.96B | 20.08%-577M | 22.62%-722M | 8.35%-933M | -30.18%-1.02B | 70.06%-782M |
-Change in payables | -187.48%-2.77B | -44.35%3.16B | 259.74%5.68B | -345.99%-3.56B | 136.84%1.45B | -104.21%-3.93B | -180.15%-1.92B | 29.48%2.4B | 69.13%1.85B | 154.94%1.1B |
-Provision for loans, leases and other losses | -108.03%-74M | 57.98%921M | 117.54%583M | 137.54%268M | -275.43%-714M | -78.56%407M | 6.93%1.9B | 2,266.67%1.78B | 33.93%75M | 40.00%56M |
-Changes in other current assets | 190.91%30M | 65.98%-33M | 90.93%-97M | -367.25%-1.07B | 197.80%400M | -194.46%-409M | 360.84%433M | 35.41%-166M | -176.49%-257M | 163.64%336M |
-Changes in other current liabilities | 617.02%729M | 86.43%-141M | -47.59%-1.04B | -135.68%-704M | 4,010.42%1.97B | 104.38%48M | 50.98%-1.1B | -368.75%-2.24B | 77.78%832M | -41.06%468M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -4.50%-441M | -117.53%-422M | -19.75%-194M | 15.63%-162M | -20.00%-192M | 37.74%-160M | 23.74%-257M | -69.35%-337M | 14.96%-199M | 41.50%-234M |
Interest received (cash flow from operating activities) | 33.68%2.32B | 17.13%1.74B | 23.28%1.48B | -6.82%1.2B | -13.93%1.29B | -2.53%1.5B | 23.02%1.54B | 6.65%1.25B | -2.49%1.17B | 28.94%1.2B |
Tax refund paid | -37.06%-2.34B | 42.88%-1.71B | -227.13%-2.99B | 20.59%-914M | 45.32%-1.15B | 58.63%-2.11B | -23.47%-5.09B | 32.42%-4.12B | 22.75%-6.1B | -25.68%-7.89B |
Other operating cash inflow (outflow) | 1M | 0 | 0 | 187M | 0 | -1M | 0 | 0 | 0 | 0 |
Operating cash flow | -30.15%11.81B | 3,358.69%16.91B | -77.91%489M | -82.67%2.21B | -2.43%12.78B | -5.64%13.09B | -18.44%13.88B | 10.83%17.01B | -25.27%15.35B | 52.34%20.54B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -8.91%-8.77B | 10.28%-8.05B | -18.84%-8.97B | 4.40%-7.55B | 15.87%-7.9B | 21.10%-9.38B | -25.56%-11.89B | -2.79%-9.47B | -6.56%-9.22B | -9.29%-8.65B |
Net intangibles purchase and sale | 14.10%-841M | -81.97%-979M | -96.35%-538M | 20.35%-274M | 20.92%-344M | 10.49%-435M | -137.07%-486M | -20.59%-205M | 76.62%-170M | -1,421.82%-727M |
Net business purchase and sale | --52M | ---- | ---- | --1.01B | ---- | -83.39%-585M | -282.29%-319M | 104.85%175M | -60,233.33%-3.61B | 101.07%6M |
Net investment product transactions | 552.10%10.75B | -335.21%-2.38B | -82.08%1.01B | 1,385.42%5.64B | 27.08%-439M | 11.34%-602M | -128.19%-679M | 172.02%2.41B | -14.20%-3.35B | -704.67%-2.93B |
Advance cash and loans provided to other parties | -148.12%-856M | -1,715.79%-345M | -5.56%-19M | -350.00%-18M | 96.99%-4M | 56.68%-133M | -162.39%-307M | 37.77%-117M | -623.08%-188M | 93.32%-26M |
Repayment of advance payments to other parties and cash income from loans | -90.54%33M | 711.63%349M | -4.44%43M | -10.00%45M | -87.92%50M | 276.36%414M | 37.50%110M | 2.56%80M | 151.61%78M | -41.51%31M |
Net changes in other investments | 47.92%71M | 585.71%48M | -98.00%7M | --350M | ---- | -414.00%-157M | 137.59%50M | -77.33%-133M | -87.50%-75M | -148.19%-40M |
Investing cash flow | 103.92%445M | -34.10%-11.35B | -974.37%-8.47B | 90.87%-788M | 20.68%-8.63B | 19.54%-10.88B | -86.20%-13.52B | 56.04%-7.26B | -33.97%-16.52B | -36.47%-12.33B |
Financing cash flow | ||||||||||
Net issuance payments of debt | -9.24%-532M | -112.84%-487M | 618.74%3.79B | -306.50%-731M | 147.52%354M | -1.22%-745M | 27.49%-736M | -167.31%-1.02B | 313.30%1.51B | -143.83%-707M |
Net common stock issuance | 10.58%-1.57B | ---1.76B | --0 | ---1B | --0 | ---- | ---- | ---- | ---- | ---- |
Increase or decrease of lease financing | -71.43%-576M | -0.90%-336M | -11.74%-333M | -9.16%-298M | -13,550.00%-273M | -100.00%-2M | ---1M | --0 | 8.46%-184M | -9.84%-201M |
Cash dividends paid | -8.86%-1.39B | 0.00%-1.28B | 16.22%-1.28B | -6.73%-1.52B | 29.22%-1.43B | 0.00%-2.02B | -0.10%-2.02B | 8.66%-2.01B | -16.05%-2.21B | -19.05%-1.9B |
Cash dividends for minorities | -9.55%-436M | -0.76%-398M | -8.22%-395M | -6.10%-365M | 8.27%-344M | 2.60%-375M | -25.00%-385M | 2.53%-308M | -47.66%-316M | -72.58%-214M |
Net other fund-raising expenses | -466.67%-17M | 99.45%-3M | 62.44%-548M | ---1.46B | ---- | 95.35%-2M | -126.06%-43M | 135.71%165M | -64.10%70M | -68.40%195M |
Financing cash flow | -6.20%-4.52B | -443.39%-4.26B | 123.07%1.24B | -218.11%-5.38B | 46.18%-1.69B | 1.29%-3.14B | -0.28%-3.18B | -181.46%-3.17B | 60.13%-1.13B | -964.53%-2.83B |
Net cash flow | ||||||||||
Beginning cash position | 6.40%41.55B | -5.80%39.06B | -4.17%41.46B | 7.57%43.27B | -8.49%40.22B | -7.39%43.95B | 27.18%47.46B | -16.69%37.32B | 14.92%44.79B | 21.02%38.98B |
Current changes in cash | 494.16%7.74B | 119.33%1.3B | -70.56%-6.74B | -261.03%-3.95B | 364.05%2.45B | 67.17%-929M | -143.03%-2.83B | 385.83%6.58B | -142.78%-2.3B | 12.72%5.38B |
Effect of exchange rate changes | -167.98%-813M | -72.38%1.2B | 101.77%4.33B | 261.89%2.15B | 120.41%593M | -328.61%-2.91B | -132.27%-678M | 140.60%2.1B | -1,289.66%-5.18B | -78.23%435M |
Cash adjustments other than cash changes | ---1M | ---- | 300.00%2M | 0.00%-1M | -100.98%-1M | --102M | ---- | --1.47B | ---- | ---- |
End cash Position | 16.66%48.48B | 6.40%41.55B | -5.80%39.06B | -4.17%41.46B | 7.57%43.27B | -8.49%40.22B | -7.39%43.95B | 27.18%47.46B | -16.69%37.32B | 14.92%44.79B |
Free cash flow | -88.66%836M | 181.29%7.37B | -57.04%-9.07B | -230.32%-5.77B | 42.95%4.43B | 142.49%3.1B | -75.24%1.28B | -10.13%5.16B | -47.75%5.74B | 139.16%10.99B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |